949
Views
19
CrossRef citations to date
0
Altmetric
Original Article

The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate

, , , , &
Pages 751-755 | Received 19 Jul 2009, Accepted 05 Oct 2009, Published online: 30 Jun 2010

Figures & data

Figure 1. Chemical structures of compound 4 [N-(9,10-dihydro-9,10-dioxoanthracen-2-yl)benzofuran-2-carboxamide] and compound 5 [N-(4-benzoylphenyl)benzofuran-2-carboxamide].

Figure 1.  Chemical structures of compound 4 [N-(9,10-dihydro-9,10-dioxoanthracen-2-yl)benzofuran-2-carboxamide] and compound 5 [N-(4-benzoylphenyl)benzofuran-2-carboxamide].

Scheme 1. Synthesis route for the preparation of compounds 4 and 5. Reagents and conditions: (a) dichloromethane, reflux 6 h; (b) triethylamine; (c), (d) N,N-dimethylformamide, 24 h.

Scheme 1.  Synthesis route for the preparation of compounds 4 and 5. Reagents and conditions: (a) dichloromethane, reflux 6 h; (b) triethylamine; (c), (d) N,N-dimethylformamide, 24 h.

Figure 2. Effect of Triton WR-1339 on lipid profile after (a) 7 h and (b) 24 h. Values are mean ± SEM from six animals in each group. CG, control group; HG, hyperlipidemic control group; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. HG is compared to CG: *p < 0.05, **p < 0.0001.

Figure 2.  Effect of Triton WR-1339 on lipid profile after (a) 7 h and (b) 24 h. Values are mean ± SEM from six animals in each group. CG, control group; HG, hyperlipidemic control group; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. HG is compared to CG: *p < 0.05, **p < 0.0001.

Table 1. Effect of compounds 4, 5, and bezafibrate on plasma lipid levels in Triton WR-1339-induced hyperlipidemic rats after 7 h and 24 h.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.